IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease

Marianna Sadagurski, Zhiyong Cheng, Aldo Rozzo, Isabella Palazzolo, Gregory R. Kelley, X. Dong, Dimitri Krainc, Morris F. White

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Aging is a major risk factor for the progression of neurodegenerative diseases, including Huntington disease (HD). Reduced neuronal IGF1 or Irs2 signaling have been shown to extend life span in mice. To determine whether Irs2 signaling modulates neurodegeneration in HD, we genetically modulated Irs2 concentrations in the R6/2 mouse model of HD. Increasing Irs2 levels in the brains of R6/2 mice significantly reduced life span and increased neuronal oxidative stress and mitochondrial dysfunction. In contrast, reducing Irs2 levels throughout the body (except in β cells, where Irs2 expression is needed to prevent diabetes onset; R6/2•Irs2 +/-•Irs2 βtg mice) improved motor performance and extended life span. The slower progression of HD-like symptoms was associated with increased nuclear localization of the transcription factor FoxO1 and increased expression of FoxO1-dependent genes that promote autophagy, mitochondrial function, and resistance to oxidative stress. Mitochondrial function improved and the number of autophagosomes increased in R6/2•Irs2 +/-•Irs2 βtg mice, whereas aggregate formation and oxidative stress decreased. Thus, our study suggests that Irs2 signaling can modulate HD progression. Since we found the expression of Irs2 to be normal in grade II HD patients, our results suggest that decreasing IRS2 signaling could be part of a therapeutic approach to slow the progression of HD.

Original languageEnglish (US)
Pages (from-to)4070-4081
Number of pages12
JournalJournal of Clinical Investigation
Volume121
Issue number10
DOIs
StatePublished - Oct 3 2011
Externally publishedYes

Fingerprint

Huntington Disease
Oxidative Stress
Autophagy
Neurodegenerative Diseases
Disease Progression
Transcription Factors
Brain
Genes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sadagurski, M., Cheng, Z., Rozzo, A., Palazzolo, I., Kelley, G. R., Dong, X., ... White, M. F. (2011). IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease. Journal of Clinical Investigation, 121(10), 4070-4081. https://doi.org/10.1172/JCI46305

IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease. / Sadagurski, Marianna; Cheng, Zhiyong; Rozzo, Aldo; Palazzolo, Isabella; Kelley, Gregory R.; Dong, X.; Krainc, Dimitri; White, Morris F.

In: Journal of Clinical Investigation, Vol. 121, No. 10, 03.10.2011, p. 4070-4081.

Research output: Contribution to journalArticle

Sadagurski, M, Cheng, Z, Rozzo, A, Palazzolo, I, Kelley, GR, Dong, X, Krainc, D & White, MF 2011, 'IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease', Journal of Clinical Investigation, vol. 121, no. 10, pp. 4070-4081. https://doi.org/10.1172/JCI46305
Sadagurski, Marianna ; Cheng, Zhiyong ; Rozzo, Aldo ; Palazzolo, Isabella ; Kelley, Gregory R. ; Dong, X. ; Krainc, Dimitri ; White, Morris F. / IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease. In: Journal of Clinical Investigation. 2011 ; Vol. 121, No. 10. pp. 4070-4081.
@article{34596642fc3b478c8593e580305b8c78,
title = "IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease",
abstract = "Aging is a major risk factor for the progression of neurodegenerative diseases, including Huntington disease (HD). Reduced neuronal IGF1 or Irs2 signaling have been shown to extend life span in mice. To determine whether Irs2 signaling modulates neurodegeneration in HD, we genetically modulated Irs2 concentrations in the R6/2 mouse model of HD. Increasing Irs2 levels in the brains of R6/2 mice significantly reduced life span and increased neuronal oxidative stress and mitochondrial dysfunction. In contrast, reducing Irs2 levels throughout the body (except in β cells, where Irs2 expression is needed to prevent diabetes onset; R6/2•Irs2 +/-•Irs2 βtg mice) improved motor performance and extended life span. The slower progression of HD-like symptoms was associated with increased nuclear localization of the transcription factor FoxO1 and increased expression of FoxO1-dependent genes that promote autophagy, mitochondrial function, and resistance to oxidative stress. Mitochondrial function improved and the number of autophagosomes increased in R6/2•Irs2 +/-•Irs2 βtg mice, whereas aggregate formation and oxidative stress decreased. Thus, our study suggests that Irs2 signaling can modulate HD progression. Since we found the expression of Irs2 to be normal in grade II HD patients, our results suggest that decreasing IRS2 signaling could be part of a therapeutic approach to slow the progression of HD.",
author = "Marianna Sadagurski and Zhiyong Cheng and Aldo Rozzo and Isabella Palazzolo and Kelley, {Gregory R.} and X. Dong and Dimitri Krainc and White, {Morris F.}",
year = "2011",
month = "10",
day = "3",
doi = "10.1172/JCI46305",
language = "English (US)",
volume = "121",
pages = "4070--4081",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "10",

}

TY - JOUR

T1 - IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease

AU - Sadagurski, Marianna

AU - Cheng, Zhiyong

AU - Rozzo, Aldo

AU - Palazzolo, Isabella

AU - Kelley, Gregory R.

AU - Dong, X.

AU - Krainc, Dimitri

AU - White, Morris F.

PY - 2011/10/3

Y1 - 2011/10/3

N2 - Aging is a major risk factor for the progression of neurodegenerative diseases, including Huntington disease (HD). Reduced neuronal IGF1 or Irs2 signaling have been shown to extend life span in mice. To determine whether Irs2 signaling modulates neurodegeneration in HD, we genetically modulated Irs2 concentrations in the R6/2 mouse model of HD. Increasing Irs2 levels in the brains of R6/2 mice significantly reduced life span and increased neuronal oxidative stress and mitochondrial dysfunction. In contrast, reducing Irs2 levels throughout the body (except in β cells, where Irs2 expression is needed to prevent diabetes onset; R6/2•Irs2 +/-•Irs2 βtg mice) improved motor performance and extended life span. The slower progression of HD-like symptoms was associated with increased nuclear localization of the transcription factor FoxO1 and increased expression of FoxO1-dependent genes that promote autophagy, mitochondrial function, and resistance to oxidative stress. Mitochondrial function improved and the number of autophagosomes increased in R6/2•Irs2 +/-•Irs2 βtg mice, whereas aggregate formation and oxidative stress decreased. Thus, our study suggests that Irs2 signaling can modulate HD progression. Since we found the expression of Irs2 to be normal in grade II HD patients, our results suggest that decreasing IRS2 signaling could be part of a therapeutic approach to slow the progression of HD.

AB - Aging is a major risk factor for the progression of neurodegenerative diseases, including Huntington disease (HD). Reduced neuronal IGF1 or Irs2 signaling have been shown to extend life span in mice. To determine whether Irs2 signaling modulates neurodegeneration in HD, we genetically modulated Irs2 concentrations in the R6/2 mouse model of HD. Increasing Irs2 levels in the brains of R6/2 mice significantly reduced life span and increased neuronal oxidative stress and mitochondrial dysfunction. In contrast, reducing Irs2 levels throughout the body (except in β cells, where Irs2 expression is needed to prevent diabetes onset; R6/2•Irs2 +/-•Irs2 βtg mice) improved motor performance and extended life span. The slower progression of HD-like symptoms was associated with increased nuclear localization of the transcription factor FoxO1 and increased expression of FoxO1-dependent genes that promote autophagy, mitochondrial function, and resistance to oxidative stress. Mitochondrial function improved and the number of autophagosomes increased in R6/2•Irs2 +/-•Irs2 βtg mice, whereas aggregate formation and oxidative stress decreased. Thus, our study suggests that Irs2 signaling can modulate HD progression. Since we found the expression of Irs2 to be normal in grade II HD patients, our results suggest that decreasing IRS2 signaling could be part of a therapeutic approach to slow the progression of HD.

UR - http://www.scopus.com/inward/record.url?scp=80053424337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053424337&partnerID=8YFLogxK

U2 - 10.1172/JCI46305

DO - 10.1172/JCI46305

M3 - Article

C2 - 21926467

AN - SCOPUS:80053424337

VL - 121

SP - 4070

EP - 4081

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 10

ER -